Spinal Metastasis and Metastatic Epidural Spinal Cord Compression

If you have cancer and a new MRI shows tumor in your spine, or you are losing strength in your legs, this page is for you. Spinal metastasis is common, treatable, and sometimes a true emergency. What happens in the next 24 to 48 hours can determine whether you keep walking.

What Is Spinal Metastasis?

A spinal metastasis is a deposit of cancer that has traveled from somewhere else in the body — most often breast, lung, prostate, kidney, or thyroid — and lodged in the bones of the spine. The spine is the most common site of bone metastasis, and roughly 30–40% of people with advanced cancer will develop one.

When tumor from the spine grows into the spinal canal and presses on the cord, doctors call it metastatic epidural spinal cord compression (MESCC) — a surgical emergency. Without prompt treatment, MESCC can take someone from walking to paralyzed in days.

At a Glance

Spinal metastasis means cancer has spread to the bones of your spine; it is the most common tumor problem spine surgeons treat
New or worsening leg weakness, numbness, or loss of bladder control is a medical emergency — go to an emergency room
The landmark Patchell trial proved that surgery followed by radiation keeps more patients walking than radiation alone
Modern care uses a decision tool called NOMS — Neurologic, Oncologic, Mechanical, and Systemic — to match treatment to you
For many patients, a shorter 'separation surgery' plus focused radiation (SBRT) now replaces large tumor-removal operations

Symptoms

Warning Signs of Cancer-Related Spine Pain

Pain that is worse at night or wakes you from sleep
Pain that gets worse when you lie down flat, and better when you sit up or stand
New back or neck pain in someone with a known cancer history
A sudden sharp pain when you cough, sneeze, or roll over (bone may have fractured)

Signs of Spinal Cord Compression — Seek Emergency Care Immediately

New weakness in your legs or difficulty standing up from a chair
Numbness or tingling starting in the feet and climbing up
A 'band' of numbness around your chest or abdomen
Loss of control of your bladder or bowels
Numbness in the saddle area (inner thighs, groin)

The most important prognostic factor for walking again is your neurologic status when treatment starts — patients still walking when they reach the operating room are overwhelmingly likely to stay walking.

Diagnosis

MRI of the Whole Spine (With and Without Contrast)

Best single test. Shows where the tumor is, how much bone is involved, and whether the spinal cord is compressed. Always image the entire spine — metastases often appear at more than one level.

Bilsky ESCC Grade

Grades 0–1: bone-only or minimal epidural disease. Grade 2: tumor touching the cord. Grade 3: cord compressed with no visible CSF around it. Grades 2 and 3 typically need surgical decompression before radiation.

CT Scan

Best look at the bone itself — how much vertebra is destroyed, whether there is a fracture, mechanical stability.

Biopsy

If this is the first hint of cancer, or if the oncologist needs updated molecular information, a CT-guided needle biopsy may be needed.

Staging (PET/CT, CT Chest/Abdomen/Pelvis, or Bone Scan)

Required to understand the full picture of systemic disease.

Types

The NOMS Decision Framework

N — Neurologic

How much is the tumor pressing on the cord (Bilsky ESCC grade)? Low-grade compression can often be treated with radiation alone. High-grade compression with a deficit typically needs surgical decompression first.

O — Oncologic (Radiosensitivity)

Some tumors (lymphoma, multiple myeloma, small cell lung cancer) melt away with conventional radiation. Others (renal cell carcinoma, melanoma, sarcoma) are 'radioresistant' and require spine SBRT with its higher, focused dose.

M — Mechanical (Spinal Instability Neoplastic Score, SINS)

SINS 0–6: stable. SINS 7–12: potentially unstable. SINS 13–18: frankly unstable — usually needs a stabilization procedure even if the tumor is radiation-sensitive.

S — Systemic

How aggressive is the rest of the cancer? Can the patient tolerate surgery? Someone with a very short life expectancy or poor performance status may be better served by radiation or cement procedures.

Treatment

Emergency Decompression — The Patchell Trial (Lancet, 2005)

Randomized 101 patients to radiation alone vs. surgical decompression + radiation. Surgery arm: 84% walking after treatment vs. 57% with radiation alone, and surgical patients kept ability to walk more than three times longer. Surgery first, then radiation is the standard for eligible MESCC patients.

Separation Surgery Plus SBRT

A shorter, targeted operation removes just enough tumor to create a 2–3 mm gap between the spinal cord and remaining disease, stabilizes the spine with screws and rods, then hands off to radiation oncology for spine SBRT (24–30 Gy in 1–3 fractions). Local control rates ~90% at one year, even for radioresistant tumors.

Spine SBRT Without Surgery

For patients with low-grade compression, stable spine, and radioresistant tumor. CCTG SC.24 trial (Sahgal, Lancet Oncology, 2021): SBRT 24 Gy in 2 fractions produced complete pain response at 3 months in 35% of patients vs. 14% for standard radiation.

Vertebroplasty and Kyphoplasty

For painful vertebral compression fractures without cord compression. Bone cement injected to stabilize the collapsed vertebra. CAFE trial showed dramatic improvement in disability and pain scores within 1 month. Often same-day outpatient treatments.

Minimally Invasive Stabilization

Percutaneous pedicle screw stabilization through small skin incisions when the spine is unstable but open operation is not needed. Very little blood loss; faster recovery — useful for patients with advanced systemic disease.

Systemic Therapy and Bone-Targeted Agents

Zoledronic acid or denosumab reduce the risk of future fractures and skeletal events — part of nearly every modern spinal metastasis plan.

Outcomes

Primary Cancer	Typical Median Survival After Spine Treatment	What to Know
Breast cancer	24–36 months	Often responsive to hormonal or targeted therapy; many long survivors
Prostate cancer	18–30 months	Usually radiation-sensitive; hormone therapy central
Renal cell carcinoma	12–24 months	Radioresistant — SBRT or surgery preferred
Thyroid cancer	24–48+ months	Often slow-growing; aggressive local treatment worthwhile
Non-small cell lung cancer	6–12 months	Highly variable with modern targeted/immunotherapy
Multiple myeloma / lymphoma	36+ months	Extremely radiation-sensitive; often no surgery needed

Ambulation: ~84% walking after treatment with surgery + radiation (Patchell trial). Among patients who arrive walking, >90% stay walking with surgical decompression. 1-year local tumor control with modern SBRT: 85–90%.

References

Patchell RA, et al. Direct decompressive surgical resection in treatment of spinal cord compression caused by metastatic cancer. Lancet. 2005;366(9486):643-648. PMID: 16112300
Laufer I, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. The Oncologist. 2013;18(6):744-751. PMID: 23709750
Fisher CG, et al. A novel classification system for spinal instability in neoplastic disease (SINS). Spine. 2010;35(22):E1221-E1229. PMID: 20562730
Laufer I, et al. Local disease control for spinal metastases following 'separation surgery' and SBRT: 186 patients. J Neurosurg Spine. 2013;18(3):207-214. PMID: 23339593
Sahgal A, et al. SBRT versus conventional EBRT in patients with painful spinal metastases: phase 2/3 trial. Lancet Oncol. 2021;22(7):1023-1033. PMID: 34126044
Berenson J, et al. Balloon kyphoplasty versus non-surgical fracture management in patients with cancer (CAFE trial). Lancet Oncol. 2011;12(3):225-235. PMID: 21333599

Our Specialists

Mohamad Bydon, MD

Neurosurgery

Timothy Witham, MD

Neurosurgery

Bakhtiar Yamini, MD

Neurosurgery

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-773-702-2123 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field